{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:54:55Z","timestamp":1783702495753,"version":"3.55.0"},"reference-count":62,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Primary Sj\u00f6gren Syndrome (pSS) is a chronic autoimmune disease characterized by epithelial atrophy, mononuclear infiltration in exocrine glands resulting in the defective function of these glands. In pSS, atrophy of the epithelium is caused by an increased amount of apoptosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The main aim of this study is to investigate the role of the apoptosis-related factors by studying Bcl-2, Fas and FasL expression in relation to the extent of inflammation as well as the effect of therapy on the expression of these mediators.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>In pSS patients (n=62) documented for their serological and clinical features, Fas, FasL and Bcl-2 plasma levels were assessed using enzyme-linked immunosorbent assays. In the same context, we investigated their expression by immunohistochemistry analysis in the labial salivary glands samples in association with the extent of inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Interestingly, our results indicated that in pSS patients, the plasmatic Bcl-2, Fas and FasL levels, which appeared to be associated with the severity of inflammation and were significantly elevated in comparison to the healthy controls. Moreover, a significant decrease in all these factors was observed in patients after combined corticosteroids-hydroxychloroquine therapy. Importantly, we report a strong positive correlation between Bcl-2 and NO levels. The immunohistochemical staining reveals a strong Bcl-2 expression in infiltrating mononuclear cells and a total absence in the acinar cells. The Bcl-2 level varies according to the severity of pathology. However, the expression of Fas and FasL was less important and predominantly localized in infiltrating mononuclear cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Our current study highlights the involvement of Bcl-2, Fas and FasL in pSS glands injury. These factors may act as useful predictor markers of a clinical course in pSS, suggesting a novel approach in the pSS patients monitoring.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871530321666210809155147","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:10:26Z","timestamp":1628536226000},"page":"328-338","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Association between Increased Bcl-2, Fas and FasL Levels and Inflammation Extent in Labial Salivary Glands During Primary Sj\u00f6gren's Syndrome"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2563-9009","authenticated-orcid":true,"given":"Sarah","family":"Benchabane","sequence":"first","affiliation":[{"name":"Laboratory of Cellular and Molecular Biology (LBCM), Cytokines and NO Synthases Group, Faculty of Biological Sciences, University of Sciences and Technology Houari Boumediene (USTHB), Algiers, Algeria | Department of Biology and Cellular Physiology, Faculty of Biological Sciences, Saad Dahlab\\'s University of Blida, Blida, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Slimani-Kaddouri","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Service, Issad Hassani Hospital (Beni-Messous), Algiers, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahbia","family":"Acheli","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Douera Hospital, Algiers, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thouraya","family":"Bendimerad-Iratene","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Service, Issad Hassani Hospital (Beni-Messous), Algiers, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redouane","family":"Mesbah","sequence":"additional","affiliation":[{"name":"Anatomical Pathology Service, Issad Hassani Hospital (Beni-Messous), Algiers, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7728-2147","authenticated-orcid":true,"given":"Chafia","family":"Touil-Boukoffa","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Biology (LBCM), Cytokines and NO Synthases Group, Faculty of Biological Sciences, University of Sciences and Technology Houari Boumediene (USTHB), Algiers, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.semarthrit.2013.04.004","volume":"43","author":"Routsias J.G.","year":"2013","unstructured":"Routsias J.G.; Goules J.D.; Charalampakis G.; Tzima S.; Papageorgiou A.; Voulgarelis M.; Malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome: an update on the pathogenesis and treatment. Semin Arthritis Rheum 2013,43(2),178-186","journal-title":"Semin Arthritis Rheum"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"Ioannidis J.P.","year":"2002","unstructured":"Ioannidis J.P.; Vassiliou V.A.; Moutsopoulos H.M.; Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 2002,46(3),741-747","journal-title":"Arthritis Rheum"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"Vitali C.","year":"2002","unstructured":"Vitali C.; Bombardieri S.; Jonsson R.; Moutsopoulos H.M.; Alexander E.L.; Carsons S.E.; Daniels T.E.; Fox P.C.; Fox R.I.; Kassan S.S.; Pillemer S.R.; Talal N.; Weisman M.H.; Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002,61(6),554-558","journal-title":"Ann Rheum Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2014.02.008","volume":"51","author":"Kivity S.","year":"2014","unstructured":"Kivity S.; Arango M.T.; Ehrenfeld M.; Tehori O.; Shoenfeld Y.; Anaya J.M.; Agmon-Levin N.; Infection and autoimmunity in Sjogren\u2019s syndrome: A clinical study and comprehensive review. J Autoimmun 2014,51,17-22","journal-title":"J Autoimmun"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.1780400515","volume":"40","author":"Konttinen Y.T.","year":"1997","unstructured":"Konttinen Y.T.; Platts L.A.; Tuominen S.; Eklund K.K.; Santavirta N.; T\u00f6rnwall J.; Sorsa T.; Hukkanen M.; Polak J.M.; Role of nitric oxide in Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 1997,40(5),875-883","journal-title":"Arthritis Rheum"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s100670070028","volume":"19","author":"Wanchu A.","year":"2000","unstructured":"Wanchu A.; Khullar M.; Sud A.; Bambery P.; Elevated nitric oxide production in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol 2000,19(5),360-364","journal-title":"Clin Rheumatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/08923973.2017.1418881","volume":"40","author":"Benchabane S.","year":"2018","unstructured":"Benchabane S.; Belguendouz H.; Behairi N.; Arroul-Lammali A.; Boudjelida A.; Youinou P.; Touil-Boukoffa C.; Cardamonin inhibits pro-inflammatory cytokine production and suppresses NO pathway in PBMCs from patients with primary Sj\u00f6gren\u2019s syndrome. Immunopharmacol Immunotoxicol 2018,40(2),126-133","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s10787-018-0499-4","volume":"26","author":"Benchabane S.","year":"2018","unstructured":"Benchabane S.; Belkhelfa M.; Belguendouz H.; Zidi S.; Boudjelida A.; Youinou P.; Touil-Boukoffa C.; Interferon-\u03b2 inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sj\u00f6gren\u2019s syndrome. Inflammopharmacology 2018,26(5),1165-1174","journal-title":"Inflammopharmacology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1177\/0394632016651273","volume":"29","author":"Benchabane S.","year":"2016","unstructured":"Benchabane S.; Boudjelida A.; Toumi R.; Belguendouz H.; Youinou P.; Touil-Boukoffa C.; A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sj\u00f6gren\u2019s syndrome. Int J Immunopathol Pharmacol 2016,29(3),386-397","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"Christodoulou M.I.","year":"2010","unstructured":"Christodoulou M.I.; Kapsogeorgou E.K.; Moutsopoulos H.M.; Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome. J Autoimmun 2010,34(4),400-407","journal-title":"J Autoimmun"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1146\/annurev.immunol.17.1.781","volume":"17","author":"Rathmell J.C.","year":"1999","unstructured":"Rathmell J.C.; Thompson C.B.; The central effectors of cell death in the immune system. Annu Rev Immunol 1999,17,781-828","journal-title":"Annu Rev Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/sj.cr.7290345","volume":"15","author":"Zhang N.","year":"2005","unstructured":"Zhang N.; Hartig H.; Dzhagalov I.; Draper D.; He Y.W.; The role of apoptosis in the development and function of T lymphocytes. Cell Res 2005,15(10),749-769","journal-title":"Cell Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.cdd.4400633","volume":"7","author":"Clemens M.J.","year":"2000","unstructured":"Clemens M.J.; van Venrooij W.J.; van de Putte L.B.A.; Apoptosis and autoimmunity. Cell Death Differ 2000,7(1),131-133","journal-title":"Cell Death Differ"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2169\/internalmedicine.40.275","volume":"40","author":"Eguchi K.","year":"2001","unstructured":"Eguchi K.; Apoptosis in autoimmune diseases. Intern Med 2001,40(4),275-284","journal-title":"Intern Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1113\/eph8802503","volume":"88","author":"Gulbins E.","year":"2003","unstructured":"Gulbins E.; Dreschers S.; Bock J.; Role of mitochondria in apoptosis. Exp Physiol 2003,88(1),85-90","journal-title":"Exp Physiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"Elmore S.","year":"2007","unstructured":"Elmore S.; Apoptosis: A review of programmed cell death. Toxicol Pathol 2007,35(4),495-516","journal-title":"Toxicol Pathol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0300-9084(99)80027-3","volume":"80","author":"Touil-Boukoffa C.","year":"1998","unstructured":"Touil-Boukoffa C.; Bauvois B.; Sanc\u00e9au J.; Hamrioui B.; Wietzerbin J.; Production of nitric oxide (NO) in human hydatidosis: Relationship between nitrite production and interferon-\u03b3 levels. Biochimie 1998,80(8-9),739-744","journal-title":"Biochimie"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/art.1780370615","volume":"37","author":"Daniels T.E.","year":"1994","unstructured":"Daniels T.E.; Whitcher J.P.; Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 1994,37(6),869-877","journal-title":"Arthritis Rheum"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/art.1780270205","volume":"27","author":"Daniels T.E.","year":"1984","unstructured":"Daniels T.E.; Labial salivary gland biopsy in Sj\u00f6gren\u2019s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984,27(2),147-156","journal-title":"Arthritis Rheum"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/0030-4220(74)90160-1","volume":"37","author":"Tarpley T.M.","year":"1974","unstructured":"Tarpley T.M.; Anderson L.G.; White C.L.; Minor salivary gland involvement in Sj\u00f6gren\u2019s syndrome. Oral Surg Oral Med Oral Pathol 1974,37(1),64-74","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fimmu.2012.00428","volume":"3","author":"Darrah E.","year":"2013","unstructured":"Darrah E.; Andrade F.; NETs: the missing link between cell death and systemic autoimmune diseases? Front Immunol 2013,3,428","journal-title":"Front Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"5981432","DOI":"10.1155\/2017\/5981432","volume":"2017","author":"Luo J.","year":"2017","unstructured":"Luo J.; Wang Y.; Yu B.; Qian H.; He Y.; Shi G.; A Potential of sFasL in Preventing Gland Injury in Sjogren\u2019s Syndrome. BioMed Res Int 2017,2017,5981432","journal-title":"BioMed Res Int"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/art.1780400617","volume":"40","author":"Nozawa K.","year":"1997","unstructured":"Nozawa K.; Kayagaki N.; Tokano Y.; Yagita H.; Okumura K.; Hasimoto H.; Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases. Arthritis Rheum 1997,40(6),1126-1129","journal-title":"Arthritis Rheum"},{"key":"ref=24","first-page":"254","volume":"37","author":"Vincent F.B.","year":"2019","unstructured":"Vincent F.B.; Bubicich M.; Downie-Doyle S.; Mackay F.; Morand E.F.; Rischmueller M.; Serum soluble Fas and Fas ligand (FasL) in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 2019,37(3)(Suppl. 118),254-256","journal-title":"Clin Exp Rheumatol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1136\/lupus-2019-000375","volume":"7","author":"Vincent F.B.","year":"2020","unstructured":"Vincent F.B.; Kandane-Rathnayake R.; Koelmeyer R.; Harris J.; Hoi A.Y.; Mackay F.; Morand E.F.; Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus. Lupus Sci Med 2020,7(1),375","journal-title":"Lupus Sci Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nm0396-317","volume":"2","author":"Tanaka M.","year":"1996","unstructured":"Tanaka M.; Suda T.; Haze K.; Nakamura N.; Sato K.; Kimura F.; Motoyoshi K.; Mizuki M.; Tagawa S.; Ohga S.; Hatake K.; Drummond A.H.; Nagata S.; Fas ligand in human serum. Nat Med 1996,2(3),317-322","journal-title":"Nat Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"6377","DOI":"10.1167\/iovs.15-16588","volume":"56","author":"Rogge M.","year":"2015","unstructured":"Rogge M.; Yin X.T.; Godfrey L.; Lakireddy P.; Potter C.A.; Del Rosso C.R.; Stuart P.M.; Therapeutic use of soluble fas ligand ameliorates acute and recurrent herpetic stromal keratitis in mice. Invest Ophthalmol Vis Sci 2015,56(11),6377-6386","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"22532","DOI":"10.1074\/jbc.274.32.22532","volume":"274","author":"Scaffidi C.","year":"1999","unstructured":"Scaffidi C.; Schmitz I.; Zha J.; Korsmeyer S.J.; Krammer P.H.; Peter M.E.; Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 1999,274(32),22532-22538","journal-title":"J Biol Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12891-017-1543-z","volume":"18","author":"Wang S.Q.","year":"2017","unstructured":"Wang S.Q.; Zhang L.W.; Wei P.; Hua H.; Is hydroxychloroquine effective in treating primary Sjogren\u2019s syndrome: A systematic review and meta-analysis. BMC Musculoskelet Disord 2017,18(1),186","journal-title":"BMC Musculoskelet Disord"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/1759720X10363246","volume":"2","author":"Vitali C.","year":"2010","unstructured":"Vitali C.; Palombi G.; Cataleta P.; Treating Sj\u00f6gren\u2019s syndrome: Insights for the clinician. Ther Adv Musculoskelet Dis 2010,2(3),155-166","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","volume":"42","author":"Vivino F.B.","year":"2016","unstructured":"Vivino F.B.; Carsons S.E.; Foulks G.; Daniels T.E.; Parke A.; Brennan M.T.; Forstot S.L.; Scofield R.H.; Hammitt K.M.; New treatment guidelines for Sj\u00f6gren\u2019s disease. Rheum Dis Clin North Am 2016,42(3),531-551","journal-title":"Rheum Dis Clin North Am"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","volume":"42","author":"Ben-Zvi I.","year":"2012","unstructured":"Ben-Zvi I.; Kivity S.; Langevitz P.; Shoenfeld Y.; Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol 2012,42(2),145-153","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s42358-020-00134-8","volume":"60","author":"Dos Reis Neto E.T.","year":"2020","unstructured":"Dos Reis Neto E.T.; Kakehasi A.M.; de Medeiros Pinheiro M.; Ferreira G.A.; Marques C.D.L.; da Mota L.M.H.; Dos Santos Paiva E.; Pileggi G.C.S.; Sato E.I.; Reis A.P.M.G.; Xavier R.M.; Provenza J.R.; Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Adv Rheumatol 2020,60(1),32","journal-title":"Adv Rheumatol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/10428190290021506","volume":"43","author":"Lagneaux L.","year":"2002","unstructured":"Lagneaux L.; Delforge A.; Dejeneffe M.; Massy M.; Bernier M.; Bron D.; Hydroxychloroquine-induced apoptosis of chronic lymphocytic leukemia involves activation of caspase-3 and modulation of Bcl-2\/bax\/ratio. Leuk Lymphoma 2002,43(5),1087-1095","journal-title":"Leuk Lymphoma"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/rheumatology\/kez242","volume":"59","author":"Bodewes I.L.A.","year":"2020","unstructured":"Bodewes I.L.A.; Gottenberg J.E.; van Helden-Meeuwsen C.G.; Mariette X.; Versnel M.A.; Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sj\u00f6gren\u2019s syndrome in the JOQUER randomized trial. Rheumatology (Oxford) 2020,59(1),107-111","journal-title":"Rheumatology (Oxford)"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1177\/0961203396005001081","volume":"5","author":"Fox R.I.","year":"1996","unstructured":"Fox R.I.; Dixon R.; Guarrasi V.; Krubel S.; Treatment of primary Sj\u00f6gren\u2019s syndrome with hydroxychloroquine: A retrospective, open-label study. Lupus 1996,5(1),S31-S36","journal-title":"Lupus"},{"key":"ref=37","first-page":"229","volume":"11","author":"Mumcu G.","year":"2013","unstructured":"Mumcu G.; Bi\u00e7ak\u00e7igil M.; Yilmaz N.; Ozay H.; Kara\u00e7ayli U.; Cimilli H.; Yavuz S.; Salivary and serum B-cell activating factor (BAFF) levels after hydroxychloroquine treatment in primary Sj\u00f6gren\u2019s syndrome. Oral Health Prev Dent 2013,11(3),229-234","journal-title":"Oral Health Prev Dent"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"Gottenberg J.E.","year":"2014","unstructured":"Gottenberg J.E.; Ravaud P.; Puechal X.; Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: The JOQUER randomized clinical trial. jama 2014,312(3),249-258","journal-title":"jama"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/10408360590888983","volume":"42","author":"Tuckermann J.P.","year":"2005","unstructured":"Tuckermann J.P.; Kleiman A.; McPherson K.G.; Reichardt H.M.; Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci 2005,42(1),71-104","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1091\/mbc.12.11.3365","volume":"12","author":"Deroo B.J.","year":"2001","unstructured":"Deroo B.J.; Archer T.K.; Glucocorticoid receptor activation of the I kappa B alpha promoter within chromatin. Mol Biol Cell 2001,12(11),3365-3374","journal-title":"Mol Biol Cell"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"18022","DOI":"10.1074\/jbc.M301812200","volume":"278","author":"Gascoyne D.M.","year":"2003","unstructured":"Gascoyne D.M.; Kypta R.M.; Vivanco Md.; Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL. J Biol Chem 2003,278(20),18022-18029","journal-title":"J Biol Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"17941","DOI":"10.1074\/jbc.274.25.17941","volume":"274","author":"Saleh A.","year":"1999","unstructured":"Saleh A.; Srinivasula S.M.; Acharya S.; Fishel R.; Alnemri E.S.; Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem 1999,274(25),17941-17945","journal-title":"J Biol Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6123(10)82001-1","volume":"182","author":"Smith L.K.","year":"2010","unstructured":"Smith L.K.; Cidlowski J.A.; Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes. Prog Brain Res 2010,182,1-30","journal-title":"Prog Brain Res"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.4049\/jimmunol.161.12.6526","volume":"161","author":"Williams M.S.","year":"1998","unstructured":"Williams M.S.; Noguchi S.; Henkart P.A.; Osawa Y.; Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J Immunol 1998,161(12),6526-6531","journal-title":"J Immunol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0002-9440(10)64913-9","volume":"160","author":"Liversidge J.","year":"2002","unstructured":"Liversidge J.; Dick A.; Gordon S.; Nitric oxide mediates apoptosis through formation of peroxynitrite and Fas\/Fas-ligand interactions in experimental autoimmune uveitis. Am J Pathol 2002,160(3),905-916","journal-title":"Am J Pathol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"20192","DOI":"10.1074\/jbc.271.33.20192","volume":"271","author":"Messmer U.K.","year":"1996","unstructured":"Messmer U.K.; Reed U.K.; Br\u00fcne B.; Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J Biol Chem 1996,271(33),20192-20197","journal-title":"J Biol Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e7059","DOI":"10.1371\/journal.pone.0007059","volume":"4","author":"Snyder C.M.","year":"2009","unstructured":"Snyder C.M.; Shroff E.H.; Liu J.; Chandel N.S.; Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members. PLoS One 2009,4(9),e7059","journal-title":"PLoS One"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0015-0282(02)03304-6","volume":"78","author":"Castro A.","year":"2002","unstructured":"Castro A.; Johnson M.C.; Anido M.; Cortinez A.; Gabler F.; Vega M.; Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis. Fertil Steril 2002,78(3),587-595","journal-title":"Fertil Steril"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"19705","DOI":"10.1074\/jbc.271.33.19705","volume":"271","author":"Lander H.M.","year":"1996","unstructured":"Lander H.M.; Jacovina A.T.; Davis R.J.; Tauras J.M.; Differential activation of mitogen-activated protein kinases by nitric oxide-related species. J Biol Chem 1996,271(33),19705-19709","journal-title":"J Biol Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/clin.1998.4556","volume":"88","author":"Kong L.","year":"1998","unstructured":"Kong L.; Ogawa N.; McGuff H.S.; Nakabayashi T.; Sakata K.M.; Masago R.; Vela-Roch N.; Talal N.; Dang H.; Bcl-2 family expression in salivary glands from patients with primary Sj\u00f6gren\u2019s syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol 1998,88(2),133-141","journal-title":"Clin Immunol Immunopathol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.med.48.1.267","volume":"48","author":"Rudin C.M.","year":"1997","unstructured":"Rudin C.M.; Thompson C.B.; Apoptosis and disease: Regulation and clinical relevance of programmed cell death. Annu Rev Med 1997,48,267-281","journal-title":"Annu Rev Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"330","DOI":"10.18632\/aging.100459","volume":"4","author":"Favaloro B.","year":"2012","unstructured":"Favaloro B.; Allocati N.; Graziano V.; Di Ilio C.; De Laurenzi V.; Role of apoptosis in disease. Aging (Albany NY) 2012,4(5),330-349","journal-title":"Aging (Albany NY)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/labinvest.3780215","volume":"81","author":"Ohlsson M.","year":"2001","unstructured":"Ohlsson M.; Skarstein K.; Bolstad A.I.; Johannessen A.C.; Jonsson R.; Fas-induced apoptosis is a rare event in Sj\u00f6gren\u2019s syndrome. Lab Invest 2001,81(1),95-105","journal-title":"Lab Invest"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/intimm\/8.7.991","volume":"8","author":"Lee R.K.","year":"1996","unstructured":"Lee R.K.; Spielman J.; Podack E.R.; Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis. Int Immunol 1996,8(7),991-1000","journal-title":"Int Immunol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1083\/jcb.151.6.1247","volume":"151","author":"Matsumura H.","year":"2000","unstructured":"Matsumura H.; Shimizu Y.; Ohsawa Y.; Kawahara A.; Uchiyama Y.; Nagata S.; Necrotic death pathway in Fas receptor signaling. J Cell Biol 2000,151(6),1247-1256","journal-title":"J Cell Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0163-7258(00)00096-6","volume":"88","author":"Sharma K.","year":"2000","unstructured":"Sharma K.; Wang R.X.; Zhang L.Y.; Yin D.L.; Luo X.Y.; Solomon J.C.; Jiang R.F.; Markos K.; Davidson W.; Scott D.W.; Shi Y.F.; Death the Fas way: Regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther 2000,88(3),333-347","journal-title":"Pharmacol Ther"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/sj.leu.2402169","volume":"15","author":"Daniel P.T.","year":"2001","unstructured":"Daniel P.T.; Wieder T.; Sturm I.; Schulze-Osthoff K.; The kiss of death: Promises and failures of death receptors and ligands in cancer therapy. Leukemia 2001,15(7),1022-1032","journal-title":"Leukemia"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/cdd.2015.3","volume":"22","author":"Peter M.E.","year":"2015","unstructured":"Peter M.E.; Hadji A.; Murmann A.E.; Brockway S.; Putzbach W.; Pattanayak A.; Ceppi P.; The role of CD95 and CD95 ligand in cancer. Cell Death Differ 2015,22(4),549-559","journal-title":"Cell Death Differ"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/cancers11050639","volume":"11","author":"Rossin A.","year":"2019","unstructured":"Rossin A.; Miloro G.; Hueber A.O.; TRAIL and FasL functions in cancer and autoimmune diseases: towards an increasing complexity. Cancers (Basel) 2019,11(5),639","journal-title":"Cancers (Basel)"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/art.1780391114","volume":"39","author":"Ogawa N.","year":"1996","unstructured":"Ogawa N.; Dang H.; Kong L.; Anaya J.M.; Liu G.T.; Talal N.; Lymphocyte apoptosis and apoptosis-associated gene expression in Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 1996,39(11),1875-1885","journal-title":"Arthritis Rheum"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1084\/jem.178.2.427","volume":"178","author":"Akbar A.N.","year":"1993","unstructured":"Akbar A.N.; Borthwick N.; Salmon M.; Gombert W.; Bofill M.; Shamsadeen N.; Pilling D.; Pett S.; Grundy J.E.; Janossy G.; The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993,178(2),427-438","journal-title":"J Exp Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3390\/ijms19082369","volume":"19","author":"Nakamura H.","year":"2018","unstructured":"Nakamura H.; Horai Y.; Shimizu T.; Kawakami A.; Modulation of apoptosis by cytotoxic mediators and cell-survival molecules in Sj\u00f6gren\u2019s syndrome. Int J Mol Sci 2018,19(8),2369","journal-title":"Int J Mol Sci"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530321666210809155147","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/195459\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530321666210809155147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:19:17Z","timestamp":1673050757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/195459\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530321666210809155147","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}